Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 33106877)

  • 21. Differential Expression and Prognostic Correlation of Immune Related Factors Between Right and Left Side Colorectal Cancer.
    Hu Y; Ding J; Wu C; Gao H; Ge M; Shao Q; Liu Y; Ye Q
    Front Oncol; 2022; 12():845765. PubMed ID: 35936748
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of multi-omics differences in left-side and right-side colon cancer.
    Huang Y; Duanmu J; Liu Y; Yan M; Li T; Jiang Q
    PeerJ; 2021; 9():e11433. PubMed ID: 34026368
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical baseline and prognostic difference of platelet lymphocyte ratio (PLR) in right-sided and let-sided colon cancers.
    Yang L; He W; Kong P; Jiang C; Yang Q; Xie Q; Xia LP
    BMC Cancer; 2017 Dec; 17(1):873. PubMed ID: 29262803
    [TBL] [Abstract][Full Text] [Related]  

  • 24. KRAS mutation status between left- and right-sided colorectal cancer: are there any differences in computed tomography?
    Yu MM; Shi D; Li Q; Li JB; Li Q; Yu RS
    Jpn J Radiol; 2023 Jan; 41(1):83-91. PubMed ID: 35976561
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PIK3CA mutation is a favorable prognostic factor in esophageal cancer: molecular profile by next-generation sequencing using surgically resected formalin-fixed, paraffin-embedded tissue.
    Yokota T; Serizawa M; Hosokawa A; Kusafuka K; Mori K; Sugiyama T; Tsubosa Y; Koh Y
    BMC Cancer; 2018 Aug; 18(1):826. PubMed ID: 30115035
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinicopathological differences and correlations between right and left colon cancer.
    Kalantzis I; Nonni A; Pavlakis K; Delicha EM; Miltiadou K; Kosmas C; Ziras N; Gkoumas K; Gakiopoulou H
    World J Clin Cases; 2020 Apr; 8(8):1424-1443. PubMed ID: 32368535
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genomic landscape and its prognostic significance in stage III colorectal cancer: JCOG1506A1, an ancillary of JCOG0910.
    Shida D; Kuchiba A; Shibata T; Hamaguchi T; Yamasaki S; Ito M; Kobatake T; Tonooka T; Masaki T; Shiozawa M; Takii Y; Uetake H; Okamura S; Ojima H; Kazama S; Takeyama H; Kanato K; Shimada Y; Murakami Y; Kanemitsu Y
    Cancer Sci; 2023 Aug; 114(8):3352-3363. PubMed ID: 37189003
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identifying important microbial and genomic biomarkers for differentiating right- versus left-sided colorectal cancer using random forest models.
    Kolisnik T; Sulit AK; Schmeier S; Frizelle F; Purcell R; Smith A; Silander O
    BMC Cancer; 2023 Jul; 23(1):647. PubMed ID: 37434131
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular Profiling of Patients With Advanced Colorectal Cancer: Princess Margaret Cancer Centre Experience.
    Chiu JW; Krzyzanowska MK; Serra S; Knox JJ; Dhani NC; Mackay H; Hedley D; Moore M; Liu G; Burkes RL; Brezden-Masley C; Roehrl MH; Craddock KJ; Tsao MS; Zhang T; Yu C; Kamel-Reid S; Siu LL; Bedard PL; Chen EX
    Clin Colorectal Cancer; 2018 Mar; 17(1):73-79. PubMed ID: 29128266
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Different treatment strategies and molecular features between right-sided and left-sided colon cancers.
    Shen H; Yang J; Huang Q; Jiang MJ; Tan YN; Fu JF; Zhu LZ; Fang XF; Yuan Y
    World J Gastroenterol; 2015 Jun; 21(21):6470-8. PubMed ID: 26074686
    [TBL] [Abstract][Full Text] [Related]  

  • 31. NGS-based oncogenic mutations analysis in advanced colorectal cancer patients improves targeted therapy prediction.
    Li W; Qiu T; Guo L; Ying J; Zhou A
    Pathol Res Pract; 2019 Mar; 215(3):483-489. PubMed ID: 30611619
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Discovering the molecular differences between right- and left-sided colon cancer using machine learning methods.
    Jiang Y; Yan X; Liu K; Shi Y; Wang C; Hu J; Li Y; Wu Q; Xiang M; Zhao R
    BMC Cancer; 2020 Oct; 20(1):1012. PubMed ID: 33076847
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Right Sided Colon Cancer as a Distinct Histopathological Subtype with Reduced Prognosis.
    Nitsche U; Stögbauer F; Späth C; Haller B; Wilhelm D; Friess H; Bader FG
    Dig Surg; 2016; 33(2):157-63. PubMed ID: 26824772
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differences Between Right and Left Colon Cancer in Beira Interior.
    Gonçalves C; Duarte L; Alves JJC
    Cureus; 2023 Apr; 15(4):e37500. PubMed ID: 37187661
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinicopathological Characteristics and Mutation Spectrum of Colorectal Adenocarcinoma With Mucinous Component in a Chinese Cohort: Comparison With Classical Adenocarcinoma.
    Chen J; Zhou L; Gao J; Lu T; Wang J; Wu H; Liang Z
    Front Oncol; 2020; 10():917. PubMed ID: 32582557
    [No Abstract]   [Full Text] [Related]  

  • 36. Genetic profile of Chinese patients with small bowel cancer categorized by anatomic location.
    Shi C; Ma J; Zhang T; Shi Y; Duan W; Huang D; Zhang H; Zeng Y
    BMC Med Genomics; 2023 Nov; 16(1):289. PubMed ID: 37974218
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical significance of multiple gene detection with a 22-gene panel in formalin-fixed paraffin-embedded specimens of 207 colorectal cancer patients.
    Gao XH; Yu GY; Hong YG; Lian W; Chouhan H; Xu Y; Liu LJ; Bai CG; Zhang W
    Int J Clin Oncol; 2019 Feb; 24(2):141-152. PubMed ID: 30612269
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of genomic alterations in Chinese colorectal cancer patients with liver metastases.
    Wang HW; Yan XL; Wang LJ; Zhang MH; Yang CH; Wei-Liu ; Jin KM; Bao Q; Li J; Wang K; Xing BC
    J Transl Med; 2021 Jul; 19(1):313. PubMed ID: 34281583
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Distribution of KRAS, DDR2, and TP53 gene mutations in lung cancer: An analysis of Iranian patients.
    Fathi Z; Mousavi SAJ; Roudi R; Ghazi F
    PLoS One; 2018; 13(7):e0200633. PubMed ID: 30048458
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeted genomic profiling identifies frequent deleterious mutations in FAT4 and TP53 genes in HBV-associated hepatocellular carcinoma.
    Huang FY; Wong DK; Tsui VW; Seto WK; Mak LY; Cheung TT; Lai KK; Yuen MF
    BMC Cancer; 2019 Aug; 19(1):789. PubMed ID: 31395065
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.